Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jansen

Showing results (71-80 of 254) with videos related to

Pageof 26
Sort By:
Human Vaccines & Immunotherapeutics|February 5, 2021
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United StatesDavid Fitz-Patrick, Mariano Young, Daniel A Scott, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B diseaseAnnaliesa S Anderson, Li Hao, Qin Jiang, et al.
Vaccine|September 10, 2019
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adultsAllison Thompson, Erik Lamberth, Joseph Severs, et al.
Vaccine|June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particlesT J Palker, J M Monteiro, M M Martin, et al.
Human Vaccines|January 27, 2011
13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge modelPhilip Fernsten, Kathryn W Mason, Xinhong Yu, et al.
The New England Journal of Medicine|November 22, 2002
A controlled trial of a human papillomavirus type 16 vaccineLaura A Koutsky, Kevin A Ault, Cosette M Wheeler, et al.
European Journal of Immunology|May 1, 1991
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosisY J Liu, J A Cairns, M J Holder, et al.
Vaccines|January 8, 2025
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal ImmunizationBing Cai, Yili Chen, Yasmeen Agosti, et al.
Vaccine|April 10, 2019
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adultsMegumi Inoue, Takuma Yonemura, Richard de Solom, et al.
The Pediatric Infectious Disease Journal|November 2, 2012
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsMichael D Nissen, Helen S Marshall, Peter C Richmond, et al.
Pageof 26

Showing results (71-80 of 254) with videos related to

Sort By:
Pageof 26
Human Vaccines & Immunotherapeutics|February 5, 2021
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United StatesDavid Fitz-Patrick, Mariano Young, Daniel A Scott, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B diseaseAnnaliesa S Anderson, Li Hao, Qin Jiang, et al.
Vaccine|September 10, 2019
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adultsAllison Thompson, Erik Lamberth, Joseph Severs, et al.
Vaccine|June 8, 2001
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particlesT J Palker, J M Monteiro, M M Martin, et al.
Human Vaccines|January 27, 2011
13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge modelPhilip Fernsten, Kathryn W Mason, Xinhong Yu, et al.
The New England Journal of Medicine|November 22, 2002
A controlled trial of a human papillomavirus type 16 vaccineLaura A Koutsky, Kevin A Ault, Cosette M Wheeler, et al.
European Journal of Immunology|May 1, 1991
Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosisY J Liu, J A Cairns, M J Holder, et al.
Vaccines|January 8, 2025
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal ImmunizationBing Cai, Yili Chen, Yasmeen Agosti, et al.
Vaccine|April 10, 2019
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adultsMegumi Inoue, Takuma Yonemura, Richard de Solom, et al.
The Pediatric Infectious Disease Journal|November 2, 2012
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsMichael D Nissen, Helen S Marshall, Peter C Richmond, et al.
Pageof 26